CLINICAL_TRIALS
trial_result
· 2013-10-22
Clinical Trial Update: A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies [Phase 1]
Summary
A Phase 1 dose-escalation trial of AS703569 in hematologic malignancies was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Haematological Malignancies | Phase 1 | Status: TERMINATED